Skip to main content
SpringerLink
Log in

Hip fracture risk with concurrent fracture-associated drugs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Emeny RT, et al. Association of Receiving Multiple, Concurrent Fracture-Associated Drugs With Hip Fracture Risk. JAMA Network Open : 13 Nov 2019. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2019.15348

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hip fracture risk with concurrent fracture-associated drugs. Reactions Weekly 1782, 9 (2019). https://doi.org/10.1007/s40278-019-72178-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-72178-x

Search

Navigation